Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ERBB2/HER2 landscape and prognostic impact: large-scale, real-world analysis across solid cancers.

ESMO open·2026
Same author

Impact of ECOG performance status 2 participants on outcomes of pivotal cancer clinical trials: a meta-analysis and meta-regression.

ESMO open·2026
Same author

Late-onset Adamantiades-Behçet's disease-systematic review and meta-analysis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023
Same author

The frequency of arthritis in Adamantiades-Behçet's disease in Greek patients.

Journal of the European Academy of Dermatology and Venereology : JEADV·2018
Same author

Impaired aortic elastic properties in patients with systemic sarcoidosis.

European journal of clinical investigation·2008
Same author

Nodular lung calcifications following varicella zoster virus pneumonia.

QJM : monthly journal of the Association of Physicians·2008

Related Experiment Videos

Cardiac sarcoidosis.

F A Mitropoulos1, C S Floudas, M A Kanakis

  • 1Department of Pediatric Cardiac Surgery, Onassis Cardiac Center, Athens, Greece.

The Thoracic and Cardiovascular Surgeon
|August 12, 2009
PubMed
Summary

Cardiac sarcoidosis, affecting 25% of sarcoidosis patients, presents serious heart issues like arrhythmias and sudden death. Early diagnosis and treatment are crucial for improving outcomes in this challenging condition.

Area of Science:

  • Cardiology
  • Immunology
  • Systemic Diseases

Background:

  • Sarcoidosis is a systemic inflammatory disease that can affect multiple organs.
  • Cardiac sarcoidosis (CS) impacts approximately 25% of sarcoidosis patients, often leading to a poor prognosis.
  • CS manifestations include conduction abnormalities, heart failure, arrhythmias, and sudden cardiac death.

Purpose of the Study:

  • To review the diagnostic modalities for cardiac sarcoidosis.
  • To summarize the current treatment strategies for cardiac sarcoidosis.
  • To highlight the challenges in diagnosing and managing CS.

Main Methods:

  • Diagnostic tools include electrocardiography, echocardiography, nuclear imaging, myocardial biopsy, and cardiac MRI.
  • Treatment involves corticosteroids, other immunosuppressants, heart failure management, antiarrhythmics, and device implantation.

Related Experiment Videos

  • Cardiac transplantation is considered for refractory cases.

    • Main Results:

    • Diagnosis of CS is challenging, necessitating a high index of suspicion.
    • A multi-faceted approach combining imaging, biopsy, and clinical suspicion is required for diagnosis.
    • Treatment strategies are tailored to patient presentation and disease severity.

    Conclusions:

    • Cardiac sarcoidosis is a significant cause of morbidity and mortality in sarcoidosis patients.
    • Prompt and accurate diagnosis is critical for effective management.
    • A combination of immunosuppression, supportive care, and advanced therapies offers management options for CS.